knee osteoarthritis
-
Biologics
Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans
September 09, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has agreed to a nationwide contract with UnitedHealthcare…
Read More » -
Biologics
Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics
June 06, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has entered into a development collaboration agreement with MTF…
Read More » -
Extremities
Finger Joint Swelling May Be a Sign of Knee Osteoarthritis
January 16, 2019 / Bob Curley A type of finger joint swelling long known to be a sign of osteoarthritis…
Read More » -
Biologics
Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) — Samumed announced today top-line data from its phase 2b trial of SM04690…
Read More » -
Biologics
Bone Therapeutics announces single intra-articular injection of viscosupplement JTA-004 delivered higher pain reduction than the reference in first study in knee osteoarthritis
Gosselies, Belgium, 17 October 2018, 6 pm CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company…
Read More » -
Extremities
Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis
June 19, 2018 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics…
Read More » -
Biologics
Bioventus Launches DUROLANE® in the US
March 05, 2018 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today launched DUROLANE, its single-injection, hyaluronic acid (HA) product used…
Read More » -
Extremities
Centrexion Therapeutics Announces First Patient Dosed in Phase 3 Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain
February 21, 2018 BOSTON–(BUSINESS WIRE)–Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-steroidal therapeutics for the treatment of chronic…
Read More » -
Sports Medicine
Zimmer Biomet Announces Positive Results from PROGRESS II Trial of Autologous Protein Solution Prepared with nSTRIDE® APS Kit
WARSAW, Ind., Dec. 22, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced…
Read More » -
Biologics
Bioventus Receives US FDA Approval for DUROLANE®
September 05, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has received US FDA approval…
Read More » -
Extremities
Centrexion Therapeutics to Present Data on CNTX-4975 from the Treatment of Knee Osteoarthritis Pain at IX SIMPAR-ISURA
March 23, 2017 BOSTON–(BUSINESS WIRE)–Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest exclusively pain-focused…
Read More » -
Extremities
Hyaluronic injections may delay time to arthroplasty in elderly patients with knee OA
By Shirley Pulaski Results of a retrospective observational study showed patients with knee osteoarthritis who were treated with intra-articular hyaluronic…
Read More »